openPR Logo
Press release

In Paediatric Vaccine Market Few top players such as GlaxoSmithCline, Merck, Sanofi, Pfizer and Novartis contribute to more than 70% of total vaccine market

01-28-2019 07:34 PM CET | Health & Medicine

Press release from: Allied Market Research

In Paediatric Vaccine Market Few top players such as

The vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins. The global pediatric vaccine market is expected to witness strong growth during the forecast period due to the launch of new products in the market.

Get the Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/438?utm_source=openpr&utm_medium=Niranjan

In-depth discussion of global pediatric vaccine market includes past and current trends with future forecast through 2020. Detailed study of market drivers, threats and opportunities would assist corporate professionals in their strategic decisions. The report also proffers detailed geographical segmentation and identifies profitable areas.

The global pediatric vaccine market is expected to grow at a healthy CAGR in next few years. Increase in growth would be primarily attributed to the improved understanding of immunology, which has resulted in the launch of new vaccines products. The technological breakthrough has led to the development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines, and others.

However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market. The emergence of vaccines as therapeutic agents has added a new dimension to the vaccine industry and it could be the answer to most of the chronic diseases including cancer. Alliances, partnerships, and collaborations by big players to expand the business could also boost the market growth.

Purchase the Report @Discount: https://www.alliedmarketresearch.com/checkout/204056?utm_source=openpr&utm_medium=Niranjan

Global Paediatric Vaccine Market by Type:

The global paediatric vaccine market is segmented by type of vaccines into different categories such as Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis, MMR, Paediatric Hormones, HIB, Allergy, and Respiratory vaccines and Other Pediatric vaccines. Pneumococcal vaccines dominate the segment followed by HIB and other combination products.

Global Paediatric Vaccine Market by Geography:

Geographically, the global paediatric vaccine market is segmented into North America, Europe, Asia-pacific and LAMEA. North America and Europe lead the global paediatric vaccine market due to the purchasing power of costly vaccines by the consumers and favorable reimbursement policies. Asia-Pacific is the emerging market for paediatric vaccines due to rising GDP and growing demand for safe and efficacious therapeutics.

Competitive Landscape:

The leading companies in the global paediatric vaccine market include GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly and Company, Pfizer, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, and others. GlaxoSmithCline leads the global vaccine market followed by Sanofi and Pfizer. Prevnar-13 (Pneumococcal vaccine), by Pfizer is the top-selling brand amongst the other vaccine products.

High-Level Analysis:

The study identifies the potential market drivers, challenges and trends. Competitive landscape section provides explicit information of the top players ruling the global paediatric vaccine market, their operating strategies, new launches, pipeline therapies, and clinical trials. Porter’s Five Forces analysis has been used to determine the attractiveness of global paediatric vaccine market. Few top players such as GlaxoSmithCline, Merck, Sanofi, Pfizer, and Novartis contribute to more than 70% of the total vaccine market. This factor strengthens the suppliers’ power.

A threat of substitute product is less due to the emergence of vaccine as therapeutic agents. An industrial rivalry is intense due to exhaustive R&D activities and clinical trials to innovate new vaccine products and vaccine delivery technology.

KEY BENEFITS

This report offers the following benefits in particular:
• Comprehensive coverage of global paediatric vaccine market along with vaccine types, market trends, drivers and restraints would assist strategist in making strategic business decisions.
• Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players.
• Explicit information on current clinical trials and R&D activities would be beneficial to gain a deeper understanding of future market trends.
• Insightful analysis of different segments helps to recognize and capitalize future opportunities within the global paediatric vaccine market.

KEY DELIVERABLES

The global paediatric vaccine market is segmented into two major categories such as type and geography.

MARKET BY TYPE
- Pneumococcal
- Varicella
- Combinations
- Poliovirus
- Hepatitis
- MMR
- Pediatric Hormones
- HIB
- Allergy and Respiratory vaccines
- Other Pediatric Vaccines

MARKET BY GEOGRAPHY
- North America
- Europe
- Asia-Pacific
- LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Paediatric Vaccine Market Few top players such as GlaxoSmithCline, Merck, Sanofi, Pfizer and Novartis contribute to more than 70% of total vaccine market here

News-ID: 1539523 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion